Yook, S.; Cai, Z.; Jeong, J. J.; Lu, Y.; Winnik, M. A.; Pignol, J. - P.; Reilly, R. M. A Dual Receptor-Targeted (Drt) Radiation Nanomedicine Labeled With 177Lu Is More Potent For Killing Human Breast Cancer Cells In Vitro That Co-Express Her2 And Egfr Than Single Receptor-Targeted (Srt) Radiation Nanomedicines. Mol. Pharmaceutics 2020, 17, 1226?1236.